The assessment of respiratory health through localized pulmonary function evaluations offers individuals convenient access to diagnostic procedures. Such evaluations are instrumental in identifying and monitoring various respiratory conditions. For example, an individual experiencing shortness of breath may seek nearby testing centers to determine the underlying cause of their symptoms.
These localized assessments yield significant advantages, including earlier detection of pulmonary diseases, facilitating timely intervention and management. The ability to easily locate testing facilities streamlines the diagnostic process, potentially improving patient outcomes and reducing the overall burden of respiratory illnesses. Historically, access to such specialized testing may have been limited, necessitating extensive travel; however, the proliferation of conveniently located centers has broadened access to essential respiratory healthcare.
The following sections will delve into the specific types of pulmonary function tests performed, the conditions they help diagnose, and what individuals can expect during the testing process. Furthermore, the discussion will address factors to consider when selecting a testing center and interpreting the results obtained from pulmonary function assessments.
1. Convenient Testing Locations
The availability of convenient testing locations directly impacts the efficacy of pulmonary function testing. “Pulmonary function testing near me” implies a demand for readily accessible diagnostic services. The proliferation of testing centers within reasonable proximity to residential areas, workplaces, and primary care facilities significantly reduces barriers to access. These barriers can include transportation costs, time constraints, and the physical burden of travel, particularly for individuals with pre-existing respiratory conditions. For instance, a patient experiencing a COPD exacerbation may benefit significantly from a nearby testing facility that can rapidly assess lung function and inform treatment decisions. The causal relationship is clear: readily available testing locations increase the likelihood of timely diagnosis and management of pulmonary diseases.
The importance of convenient testing extends beyond immediate symptom management. Regular monitoring of lung function is crucial for individuals with chronic respiratory conditions, such as asthma and cystic fibrosis. Frequent testing allows healthcare providers to track disease progression, adjust medication regimens, and implement preventative measures. If testing locations are inconvenient or inaccessible, patients may be less likely to adhere to recommended monitoring schedules, leading to delayed diagnosis of complications and potentially poorer long-term outcomes. Examples include mobile testing units deployed in rural areas or pop-up clinics in underserved communities, demonstrating strategies to overcome geographical barriers and improve accessibility.
In conclusion, convenient testing locations are a fundamental component of effective pulmonary healthcare delivery. “Pulmonary function testing near me” embodies the principle of accessibility and underscores the need for strategically located diagnostic facilities. Challenges remain in ensuring equitable access across diverse populations and geographic regions. Continued efforts to expand the availability of convenient testing locations are essential for improving respiratory health outcomes and reducing the burden of pulmonary diseases.
2. Respiratory Condition Diagnosis
The imperative of accurate respiratory condition diagnosis is inextricably linked to the accessibility of “pulmonary function testing near me.” Timely and precise diagnosis hinges upon the availability of convenient pulmonary function testing. The ability to swiftly access these tests following the onset of respiratory symptoms, or as part of a routine monitoring protocol, directly impacts the course of disease management. For instance, a patient presenting with chronic cough and shortness of breath can undergo spirometry at a nearby facility, potentially leading to the diagnosis of COPD or asthma. Without such accessibility, diagnosis may be delayed, resulting in disease progression and diminished quality of life. The cause-and-effect relationship underscores the critical need for readily available testing centers.
Pulmonary function testing, encompassing spirometry, lung volume measurements, and diffusion capacity assessments, forms a cornerstone of respiratory diagnostics. The proximity of these services facilitates differential diagnosis, allowing clinicians to distinguish between obstructive and restrictive lung diseases, assess the severity of impairment, and monitor treatment response. Consider the case of a patient undergoing treatment for asthma. Regular pulmonary function tests performed at a nearby clinic provide objective data on bronchodilator effectiveness and disease control, enabling physicians to adjust medication accordingly. This data-driven approach, facilitated by accessible testing, minimizes reliance on subjective symptom reporting and promotes personalized, evidence-based care. Furthermore, readily available testing empowers patients to actively participate in their healthcare management by understanding their lung function metrics and recognizing early warning signs of deterioration.
In summary, “pulmonary function testing near me” represents a critical infrastructure component for effective respiratory condition diagnosis. The accessibility of these services directly influences the timeliness and accuracy of diagnostic evaluations, impacting treatment outcomes and patient well-being. Challenges remain in ensuring equitable access to testing across diverse populations and geographic areas. The continued expansion and strategic placement of pulmonary function testing facilities are essential to meet the growing demand for respiratory healthcare and improve the overall burden of respiratory diseases.
3. Localized Test Availability
The concept of localized test availability is intrinsically linked to the phrase “pulmonary function testing near me,” highlighting the critical importance of accessible diagnostic services for respiratory health. The presence of conveniently located testing facilities directly impacts the timeliness of diagnosis, management, and monitoring of pulmonary conditions.
-
Reduced Travel Burden
Localized availability minimizes the burden of travel for patients, especially those with impaired respiratory function. Lengthy journeys to distant testing centers can exacerbate symptoms, increasing patient discomfort and potentially affecting test results. The availability of nearby facilities alleviates these challenges, promoting patient compliance and ensuring more accurate assessments. For instance, an elderly patient with severe COPD may find it significantly easier to attend a local clinic for regular spirometry compared to traveling several hours to a specialized center.
-
Improved Timeliness of Diagnosis
Proximity to testing facilities facilitates quicker diagnosis and intervention. Delays in diagnosis can lead to disease progression and increased morbidity. Readily available testing allows healthcare providers to promptly assess lung function, identify underlying respiratory conditions, and initiate appropriate treatment plans. In acute situations, such as suspected asthma exacerbations or pneumonia, immediate access to pulmonary function testing can be life-saving.
-
Enhanced Monitoring of Chronic Conditions
For individuals with chronic respiratory diseases, regular monitoring is crucial for effective disease management. Localized test availability enables more frequent and convenient monitoring of lung function, allowing healthcare providers to track disease progression, assess treatment response, and adjust management strategies accordingly. This proactive approach can help prevent exacerbations, improve quality of life, and reduce healthcare costs. Consider a patient with cystic fibrosis who requires frequent lung function assessments to monitor disease progression and guide therapy. Nearby testing simplifies adherence to the monitoring schedule.
-
Increased Patient Engagement
The ease of access to testing services positively influences patient engagement in their healthcare. When testing is readily available, patients are more likely to participate in regular screenings and follow-up appointments. This increased engagement can lead to earlier detection of respiratory problems, improved adherence to treatment regimens, and a stronger sense of personal responsibility for their respiratory health. Patients can more easily integrate pulmonary function testing into their routine healthcare, enhancing overall health outcomes.
In conclusion, localized test availability is a cornerstone of effective respiratory healthcare. The concept of “pulmonary function testing near me” underscores the significance of accessible diagnostic services in ensuring timely diagnosis, effective management, and improved outcomes for individuals with pulmonary conditions. By reducing travel burdens, improving diagnostic timelines, and enhancing monitoring capabilities, localized testing plays a vital role in promoting respiratory health and well-being.
4. Spirometry Test Proximity
Spirometry test proximity is fundamentally linked to the concept of “pulmonary function testing near me.” The accessibility of spirometry, a primary component of pulmonary function assessment, significantly impacts the timeliness and effectiveness of respiratory healthcare. Increased proximity translates directly to reduced patient burden, fostering greater compliance with recommended testing schedules. Delays in obtaining spirometry results, due to geographical distance or limited availability, can impede timely diagnosis and management of respiratory conditions. For example, a patient experiencing an asthma exacerbation requires immediate assessment; readily available spirometry allows for rapid diagnosis and initiation of appropriate therapy, potentially preventing severe complications and hospitalizations.
The importance of spirometry test proximity extends beyond acute care settings. Regular spirometry is crucial for monitoring the progression of chronic respiratory diseases such as COPD and cystic fibrosis. Frequent testing allows healthcare providers to track lung function decline, adjust medication regimens, and implement preventative strategies. If spirometry services are located far from a patient’s residence or workplace, adherence to recommended monitoring schedules may be compromised, leading to delayed detection of disease progression and poorer long-term outcomes. Mobile spirometry units deployed in rural areas or partnerships between primary care practices and local pulmonary function laboratories represent strategies to improve accessibility and overcome geographical barriers.
In summary, spirometry test proximity is an indispensable element of accessible pulmonary healthcare. The phrase “pulmonary function testing near me” inherently encompasses the need for readily available spirometry services. Challenges remain in ensuring equitable access to spirometry across diverse populations and geographic regions. Continued efforts to expand the availability of conveniently located spirometry facilities are essential for improving respiratory health outcomes and reducing the burden of pulmonary diseases. This includes investment in infrastructure, training healthcare professionals, and promoting awareness of the importance of regular spirometry testing.
5. Lung Volume Assessment
The relationship between lung volume assessment and “pulmonary function testing near me” centers on the comprehensive nature of respiratory diagnostics. While spirometry, as a component of pulmonary function testing, measures the rate at which air can be inhaled and exhaled, it does not directly measure residual volume, the air remaining in the lungs after maximal exhalation. Lung volume assessment, often performed using body plethysmography or gas dilution techniques, provides a more complete picture of lung capacity. Thus, accessibility to “pulmonary function testing near me” inherently necessitates consideration of whether that “near me” location offers complete pulmonary function testing, including lung volume assessment. For instance, a patient with suspected restrictive lung disease requires lung volume assessment to differentiate between intrinsic lung disease and chest wall abnormalities, information that cannot be obtained solely through spirometry. If the nearest testing facility only offers spirometry, diagnosis and appropriate management could be significantly delayed.
The practical significance of readily accessible lung volume assessment is evident in the management of various respiratory conditions. In patients with COPD, lung volume assessment can help quantify air trapping, a phenomenon where air is retained in the lungs, leading to hyperinflation and reduced respiratory efficiency. Monitoring changes in lung volumes over time can inform treatment decisions, such as the initiation or adjustment of bronchodilator therapy or pulmonary rehabilitation programs. Similarly, in patients with interstitial lung diseases like pulmonary fibrosis, lung volume assessment helps assess the severity of restriction and track disease progression. The accessibility of these assessments enables more precise and timely intervention, ultimately improving patient outcomes. Therefore, simply having access to “pulmonary function testing near me” is insufficient; the scope of available tests must include lung volume assessments for comprehensive respiratory evaluation.
In conclusion, the connection between lung volume assessment and “pulmonary function testing near me” underscores the necessity for accessible and comprehensive respiratory diagnostics. The lack of lung volume assessment in nearby testing facilities presents a significant limitation in accurately diagnosing and managing a range of pulmonary conditions. Efforts to expand the availability of complete pulmonary function testing, including lung volume assessment, are crucial to ensure that patients receive the most accurate and timely care. This is particularly important in rural or underserved areas, where access to specialized diagnostic services may be limited.
6. Nearby Bronchodilator Responsiveness
The assessment of bronchodilator responsiveness, when integrated with accessible pulmonary function testing, provides critical insights into reversible airflow limitation. The proximity of bronchodilator responsiveness testing, embodied in the concept of “pulmonary function testing near me,” directly influences the timeliness of diagnosis and management of obstructive airway diseases.
-
Diagnostic Differentiation
Bronchodilator responsiveness testing aids in distinguishing between asthma and chronic obstructive pulmonary disease (COPD). A significant improvement in lung function following bronchodilator administration is indicative of asthma, whereas limited or no response suggests COPD or irreversible airway obstruction. Readily available testing facilitates this diagnostic process, enabling appropriate treatment strategies. In the absence of accessible bronchodilator responsiveness testing, diagnostic uncertainty can lead to inappropriate treatment regimens and suboptimal patient outcomes.
-
Treatment Optimization
The degree of bronchodilator responsiveness informs the selection and titration of bronchodilator medications. Patients exhibiting a substantial response may benefit from higher doses or more frequent administration of bronchodilators. Conversely, patients with minimal responsiveness may require alternative therapies, such as inhaled corticosteroids or long-acting muscarinic antagonists. Nearby testing enables clinicians to tailor treatment plans based on objective physiological data, optimizing therapeutic efficacy and minimizing adverse effects.
-
Disease Severity Assessment
Bronchodilator responsiveness testing contributes to the assessment of disease severity in individuals with obstructive airway diseases. The magnitude of improvement in lung function following bronchodilator administration correlates with the degree of airway reversibility and overall disease activity. Accessible testing allows for serial assessments to monitor disease progression and evaluate the effectiveness of long-term management strategies. A decline in bronchodilator responsiveness may indicate worsening airway inflammation or remodeling, prompting adjustments in treatment.
-
Patient Management Strategies
The results of bronchodilator responsiveness testing influence patient education and self-management strategies. Patients who demonstrate significant improvements with bronchodilators can be educated on the importance of adherence to prescribed medication regimens and the appropriate use of inhaler devices. Conversely, patients with limited responsiveness may require counseling on alternative strategies, such as pulmonary rehabilitation or smoking cessation. Nearby testing facilitates these educational efforts, enabling clinicians to provide personalized guidance and support.
The availability of “pulmonary function testing near me” is enhanced when it encompasses bronchodilator responsiveness testing, allowing for the application of test results in the context of diagnostic specificity, treatment optimization, disease severity assessment, and holistic patient management, thereby contributing to improved clinical care.
7. Diffusion Capacity Evaluation
Diffusion capacity evaluation, specifically the measurement of diffusing capacity of the lungs for carbon monoxide (DLCO), represents a critical component of comprehensive pulmonary function testing. Its availability in proximity, as suggested by “pulmonary function testing near me,” directly impacts the diagnostic accuracy and management of various respiratory diseases.
-
Gas Exchange Assessment
DLCO measures the efficiency of gas transfer from the alveoli into the pulmonary capillaries. This evaluation is vital for identifying conditions affecting the alveolar-capillary membrane, such as pulmonary fibrosis, emphysema, and pulmonary vascular diseases. For example, a patient exhibiting shortness of breath might undergo DLCO testing at a nearby clinic to determine if the underlying cause is impaired gas exchange due to thickening of the alveolar membrane. The proximity of such testing directly affects the speed and accuracy of diagnosis.
-
Diagnostic Specificity
While spirometry assesses airflow, DLCO provides complementary information about the integrity of the lung parenchyma. Integrating DLCO into the diagnostic workup enhances the specificity of pulmonary function testing, enabling clinicians to differentiate between obstructive and restrictive lung diseases, and to identify subtle abnormalities that may be missed by spirometry alone. Consider a patient with normal spirometry but persistent dyspnea; a reduced DLCO might suggest early-stage interstitial lung disease, prompting further investigation. The accessibility of DLCO testing facilities thus expands the scope and precision of diagnostic evaluations.
-
Disease Monitoring
DLCO is valuable for monitoring the progression of certain lung diseases and assessing the response to treatment. In patients with pulmonary fibrosis, serial DLCO measurements can track disease activity and inform therapeutic decisions. Similarly, in patients with emphysema, changes in DLCO can reflect the degree of alveolar destruction and the effectiveness of interventions such as smoking cessation or pulmonary rehabilitation. The convenience of “pulmonary function testing near me,” including DLCO assessment, facilitates regular monitoring and timely adjustments to management plans.
-
Pre-operative Evaluation
DLCO is often incorporated into pre-operative risk assessments for patients undergoing lung resection or other thoracic surgeries. A low DLCO indicates impaired gas exchange capacity, increasing the risk of post-operative complications such as respiratory failure. Having access to DLCO testing allows clinicians to accurately evaluate surgical candidates and optimize pre-operative management strategies. Proximity to testing is particularly important for patients with pre-existing respiratory conditions who require timely pre-operative clearance.
In conclusion, the value of “pulmonary function testing near me” is significantly enhanced by the inclusion of diffusion capacity evaluation. The ability to readily access DLCO testing facilitates accurate diagnosis, effective monitoring, and informed management of a wide range of respiratory disorders, ultimately improving patient outcomes. The lack of local DLCO testing capabilities represents a significant limitation in comprehensive pulmonary healthcare delivery.
8. Asthma Management Support
Effective asthma management necessitates proactive monitoring and tailored interventions. The accessibility of “pulmonary function testing near me” is integral to providing comprehensive support for individuals with asthma.
-
Objective Assessment of Airflow Limitation
Pulmonary function tests, particularly spirometry, provide objective measurements of airflow obstruction, a hallmark of asthma. These measurements assist in confirming the diagnosis of asthma, assessing disease severity, and monitoring response to treatment. For instance, a patient presenting with recurrent wheezing and shortness of breath can undergo spirometry at a nearby clinic to quantify airflow limitation and establish a baseline for future comparisons. Proximity to testing facilities enables timely assessment and informed clinical decision-making.
-
Guidance on Medication Adjustment
Regular pulmonary function testing informs medication adjustments based on objective changes in lung function. Inadequate control of asthma symptoms may necessitate an increase in controller medication dosage, addition of alternative therapies, or evaluation of inhaler technique. Conversely, sustained control of asthma may warrant a stepwise reduction in medication intensity. Readily available testing facilitates frequent monitoring, enabling clinicians to personalize treatment plans and minimize medication-related side effects.
-
Early Detection of Exacerbations
Changes in pulmonary function can serve as early warning signs of impending asthma exacerbations. A decline in forced expiratory volume in one second (FEV1) may indicate worsening airway inflammation and increased risk of acute symptoms. Prompt identification of exacerbations allows for timely interventions, such as increased use of rescue medications or initiation of oral corticosteroids. The accessibility of “pulmonary function testing near me” promotes proactive management and potentially prevents severe asthma attacks and hospitalizations.
-
Personalized Action Plans
Pulmonary function testing can be incorporated into personalized asthma action plans. These plans outline specific steps to take based on changes in symptoms and lung function measurements. Patients are instructed to monitor their peak expiratory flow rate (PEFR) at home using a portable peak flow meter and to adjust their medications accordingly. Regular follow-up visits with pulmonary function testing enable clinicians to refine action plans and reinforce self-management skills. The availability of nearby testing centers supports ongoing patient education and empowerment.
The integration of pulmonary function testing into asthma management protocols enhances the quality of care and improves patient outcomes. “Pulmonary function testing near me” represents a critical component of accessible and effective asthma management support, enabling objective assessment, informed treatment decisions, early detection of exacerbations, and personalized action planning.
9. COPD Monitoring Options
Effective management of Chronic Obstructive Pulmonary Disease (COPD) relies heavily on consistent monitoring to track disease progression and adjust treatment strategies. The proximity of suitable COPD monitoring options, facilitated by “pulmonary function testing near me,” is crucial for achieving optimal patient outcomes.
-
Spirometry for Disease Progression Tracking
Spirometry serves as a primary tool for assessing airflow limitation in COPD patients. Regular spirometry measurements, including Forced Expiratory Volume in one second (FEV1) and Forced Vital Capacity (FVC), allow healthcare providers to track disease progression and identify potential exacerbations. For example, a significant decline in FEV1 over a six-month period may indicate worsening airflow obstruction and necessitate adjustments to the patient’s treatment plan. The convenience of local “pulmonary function testing near me” ensures timely and frequent assessments.
-
Lung Volume Measurements for Emphysema Assessment
Lung volume measurements, such as residual volume (RV) and total lung capacity (TLC), are valuable in characterizing the severity of emphysema in COPD patients. Elevated RV and TLC indicate air trapping and hyperinflation, contributing to breathlessness and reduced exercise capacity. Serial lung volume measurements can monitor the effectiveness of interventions aimed at reducing air trapping, such as bronchodilator therapy and pulmonary rehabilitation. Therefore, COPD monitoring options available near the patient should include these more sophisticated tests, contributing to more precise management.
-
DLCO for Gas Exchange Efficiency
The diffusing capacity of the lungs for carbon monoxide (DLCO) assesses the efficiency of gas exchange in the lungs. A reduced DLCO in COPD patients may indicate emphysematous destruction of the alveolar-capillary membrane, limiting oxygen uptake and carbon dioxide removal. Monitoring DLCO over time can provide insights into the rate of disease progression and the impact of interventions designed to preserve lung parenchyma. The practicality of “pulmonary function testing near me” hinges on the availability of DLCO measurements as a vital COPD monitoring component.
-
Exacerbation Frequency and Severity Monitoring
Tracking the frequency and severity of COPD exacerbations is essential for guiding long-term management strategies. Frequent exacerbations are associated with accelerated disease progression, increased morbidity, and reduced quality of life. Monitoring exacerbation rates allows healthcare providers to identify patients at high risk for future events and to implement strategies aimed at prevention, such as vaccinations, smoking cessation counseling, and optimization of inhaled therapies. Accessible COPD monitoring options should include a systematic approach for documenting and assessing exacerbations.
The integrated approach to COPD monitoring, incorporating spirometry, lung volume assessments, DLCO measurements, and exacerbation tracking, enables healthcare providers to tailor treatment plans and improve patient outcomes. The proximity of comprehensive “pulmonary function testing near me” is paramount for facilitating frequent and convenient monitoring, ensuring optimal management of this chronic respiratory disease.
Frequently Asked Questions
The following questions address common inquiries regarding accessing pulmonary function testing in one’s local area. Understanding these aspects can facilitate informed decisions about respiratory health.
Question 1: What conditions necessitate seeking “pulmonary function testing near me”?
Persistent cough, shortness of breath, wheezing, or a history of smoking are common indicators. Individuals with known respiratory conditions, such as asthma or COPD, may require routine testing for monitoring.
Question 2: How is a suitable “pulmonary function testing near me” location identified?
Consulting with a primary care physician is recommended. Online directories of medical facilities can also be utilized. Verify the center’s accreditation and the qualifications of its staff.
Question 3: What types of tests are commonly included in “pulmonary function testing near me”?
Spirometry, lung volume measurements, and diffusion capacity testing are frequently performed. The specific tests offered may vary depending on the facility.
Question 4: How should one prepare for “pulmonary function testing near me”?
Avoid smoking or using bronchodilators for a specified period before the test, as instructed by the testing center. Wear loose-fitting clothing that does not restrict breathing.
Question 5: What is the duration of “pulmonary function testing near me”?
The duration varies depending on the number of tests performed. A typical appointment may last between 30 minutes and one hour.
Question 6: What should one expect following “pulmonary function testing near me”?
Results are typically forwarded to the referring physician for interpretation. Follow-up appointments may be scheduled to discuss the results and develop a management plan.
Accessibility to pulmonary function testing plays a crucial role in respiratory health management. Early detection and monitoring can lead to improved outcomes.
The subsequent section will delve into the potential costs associated with pulmonary function testing and explore available resources for financial assistance.
Essential Considerations
This section provides critical guidance for individuals seeking readily accessible pulmonary function testing. Careful attention to these factors can improve the accuracy and utility of the testing process.
Tip 1: Verify Facility Accreditation: Ensure that the chosen facility possesses accreditation from a recognized organization. Accreditation signifies adherence to established quality standards and competent operation.
Tip 2: Inquire About Technician Credentials: Confirm that the technicians performing the tests are certified respiratory therapists or have equivalent qualifications. Qualified personnel contribute to accurate and reliable results.
Tip 3: Clarify Testing Protocols: Understand the specific testing protocols used at the facility. Standardized procedures minimize variability and enhance comparability of results over time.
Tip 4: Confirm Report Generation Procedures: Determine how test results are reported and transmitted to the referring physician. Timely and accurate reporting is essential for informed clinical decision-making.
Tip 5: Ascertain Equipment Calibration Frequency: Ask about the frequency of equipment calibration. Properly calibrated equipment is crucial for generating reliable measurements.
Tip 6: Address Pre-Test Preparation Instructions: Carefully follow all pre-test preparation instructions provided by the facility. Adherence to these instructions is vital for accurate test results.
Thorough evaluation of these factors ensures that individuals receive high-quality pulmonary function testing services, contributing to improved respiratory healthcare.
The subsequent section presents a summary of the key findings and implications discussed throughout this exploration of localized pulmonary function testing.
Conclusion
This exploration of “pulmonary function testing near me” has underscored the critical role of accessible respiratory diagnostic services. The proximity of such testing directly impacts the timeliness of diagnosis, effectiveness of management, and overall well-being of individuals with pulmonary conditions. From facilitating early detection of respiratory illnesses to enabling personalized treatment strategies, localized pulmonary function testing emerges as a cornerstone of comprehensive respiratory healthcare. The availability of spirometry, lung volume assessments, diffusion capacity evaluations, and bronchodilator responsiveness testing within reasonable geographic proximity enhances patient compliance, promotes proactive monitoring, and improves clinical outcomes. The absence of readily accessible testing options can lead to delays in diagnosis, suboptimal treatment regimens, and increased risk of complications.
The findings presented herein call for a sustained commitment to expanding access to pulmonary function testing services. Strategic placement of testing facilities, investment in qualified personnel, and promotion of awareness regarding the importance of respiratory health are essential steps. By prioritizing accessibility and comprehensiveness, the healthcare community can ensure that individuals receive the timely and accurate diagnostic evaluations necessary to manage pulmonary conditions effectively and enhance their quality of life. Continued efforts to address disparities in access to pulmonary function testing will contribute to a healthier population and a reduced burden of respiratory disease.
